Discover 282 paid clinical trials in South Dakota. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
South Dakota offers a range of options for both healthy volunteers interested in paid clinical studies and individuals with specific health conditions. Major research hubs in Sioux Falls, Rapid City, and Aberdeen are currently recruiting participants, allowing access to groundbreaking treatments and advanced medical support.
Filter
1
Filter results
Results: 282
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Boston MA, Lake Success NY, The Bronx NY, New York NY,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase3, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Location: York PA, Bethesda MD, Charlotte NC, Columbus OH,
Sponsor: Tempus AI
Sex: All
Age: 0+
Code: NCT07154823
Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, Hartford CT, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase3, Recruiting
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
for
Endometrial Cancer
Location: Miami Beach FL, Fort Lauderdale FL, Miami FL,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT07022483
Phase3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Shirley NY, Sherbrooke, Mineola NY, Lake Success NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase2, Phase3, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Fall River MA, Flushing NY, New York NY, Albany NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
for
Pancreatic Cancer, PDAC,
Location: Boston MA, Hartford CT, New York NY, Philadelphia PA,
Sponsor: Revolution Medicines, Inc.
Sex: All
Age: 18+
Code: NCT07252232
Phase3, Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
for
Alcohol Use Disorder
Location: Boston MA, Foxborough MA, Providence RI, The Bronx NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07219953
Phase3, Recruiting
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
for
Solid Tumours
Location: Pittsburgh PA, Sioux Falls SD, Fort Worth TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07160725
Phase1, Phase2, Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Moncton, Rimouski, Boston MA, Quebec, Sherbrooke,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase2, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase3, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Stony Brook NY, Commack NY, Berlin Corners VT,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New Haven CT, Lebanon NH, Commack NY, Trumbull CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase2, Phase3, Recruiting
Alleviant ALLAY-HFrEF Study
for
Heart Failure
Location: Boston MA, Quebec, New York NY, Montreal, Englewood NJ,
Sponsor: Alleviant Medical, Inc.
Sex: All
Age: 18+
Code: NCT06812533
Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee